Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Klarity Medical and Equipment (GZ) CoBJSE:920072 46 Return-on-Tangible-Equity is 23.00% as of Jun. 2026, which is 0% above its 10-year median of 22.96. GuruFocus rates BJSE:920072 with a GF Score™ of 46/100. The stock has 3 warning signs investors should review. Among 757 Medical Devices & Instruments companies, Klarity Medical and Equipment (GZ) Co ranks better than 70.15% on this metric.
The historical rank and industry rank for Klarity Medical and Equipment (GZ) Co's Return-on-Tangible-Equity or its related term are showing as below:
BJSE:920072'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 9.19 Med: 22.96 Max: 30.34
Current: 12.22
During the past 12 years, Klarity Medical and Equipment (GZ) Co's highest Return-on-Tangible-Equity was 30.34%. The lowest was 9.19%. And the median was 22.96%.
BJSE:920072's Return-on-Tangible-Equity is ranked better than 70.15% of 757
companies
in the Medical Devices & Instruments industry
Industry Median: 4.67
vs BJSE:920072: 12.22
Klarity Medical and Equipment (GZ) Co (BJSE:920072) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Klarity Medical and Equipment (GZ) Co Return-on-Tangible-Equity Related Terms
Klarity Medical and Equipment (GZ) Co Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Klarity Medical and Equipment (GZ) Co Return-on-Tangible-Equity Chart
BJSE:920072 vs ABT, SYK, MDT: Return-on-Tangible-Equity Comparison
For the Medical Devices subindustry, Klarity Medical and Equipment (GZ) Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Klarity Medical and Equipment (GZ) Co Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Klarity Medical and Equipment (GZ) Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Klarity Medical and Equipment (GZ) Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Jun. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 23.00% mean?
Klarity Medical and Equipment (GZ) Co (BJSE:920072) has a Return-on-Tangible-Equity of 23.00% as of Jun. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Klarity Medical and Equipment (GZ) Co and its competitors. This is near median its historical median of 22.96. Over the past decade, Klarity Medical and Equipment (GZ) Co's Return-on-Tangible-Equity has ranged from 9.19 to 30.34. According to the industry distribution chart, Klarity Medical and Equipment (GZ) Co ranks #226 out of 757 companies in the Medical Devices & Instruments industry, placing it in the top 29.9%.
Is Klarity Medical and Equipment (GZ) Co's Return-on-Tangible-Equity too high?
Klarity Medical and Equipment (GZ) Co's current Return-on-Tangible-Equity of 23.00% is near median its 10-year median of 22.96. Over the past 10 years, this metric has ranged from a low of 9.19 to a high of 30.34. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.67. Klarity Medical and Equipment (GZ) Co's value of 23.00% is 392.5% above this industry median. Based on the distribution chart, Klarity Medical and Equipment (GZ) Co ranks #226 out of 757 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Klarity Medical and Equipment (GZ) Co has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Klarity Medical and Equipment (GZ) Co's Return-on-Tangible-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Klarity Medical and Equipment (GZ) Co ranks #226 out of 757 companies for Return-on-Tangible-Equity. This puts Klarity Medical and Equipment (GZ) Co in the upper half of its industry. The industry median Return-on-Tangible-Equity is 4.67. Klarity Medical and Equipment (GZ) Co's value of 23.00% is 392.5% above this benchmark. Historically, Klarity Medical and Equipment (GZ) Co's own Return-on-Tangible-Equity has ranged from 9.19 to 30.34 over the past decade. While the company's 10-year median is 22.96 vs. the industry median of 4.67, Klarity Medical and Equipment (GZ) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.67, based on 757 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Klarity Medical and Equipment (GZ) Co's current Return-on-Tangible-Equity of 23.00% is 392.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Klarity Medical and Equipment (GZ) Co and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Klarity Medical and Equipment (GZ) Co's current Return-on-Tangible-Equity is 23.00%, which is near median its own 10-year median of 22.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Klarity Medical and Equipment (GZ) Co stock overvalued right now?
Klarity Medical and Equipment (GZ) Co (BJSE:920072) has a current Return-on-Tangible-Equity of 23.00%. The current Return-on-Tangible-Equity is 23.00%, which is near median its 10-year median of 22.96 and 392.5% above the Medical Devices & Instruments industry median of 4.67. Klarity Medical and Equipment (GZ) Co's overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Klarity Medical and Equipment (GZ) Co (BJSE:920072), the current Return-on-Tangible-Equity is 23.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920072 has been successfully added to your 
